Keybank National Association Sangamo Therapeutics, Inc Transaction History

Keybank National Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$9.51 - $16.6 $319,669 - $557,992	-33,614 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$13.05 - $19.05 $70,717 - $103,231	-5,419 Reduced 13.88%	33,614 $570,000
Q2 2018 Aug 08, 2018	BUY	$13.9 - $19.8 $193,501 - $275,635	13,921 Added 55.44%	39,033 $554,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $212,039 - $334,565	-12,697 Reduced 33.58%	25,112 $477,000
Q4 2017 Feb 08, 2018	SELL	$11.6 - $17.35 $43,128 - $64,507	-3,718 Reduced 8.95%	37,809 $620,000
Q3 2017 Nov 02, 2017	SELL	$8.4 - $15.0 $366,492 - $654,450	-43,630 Reduced 51.23%	41,527 $623,000
Q2 2017 May 14, 2018	SELL	N/A	-50,090 Reduced 37.04%	85,157 $749,000
Q4 2016 May 14, 2018	BUY	N/A	135,247	135,247 $413,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $335M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.